Ainnocence Press Releases - EIN Presswire - Press Release Distribution Service

Published on August 12, 2026 - 16:00 GMT

Ainnocence's AINN-P1 Demonstrates Efficient Protein Prediction and Antibody Engineering

How does a 167M-parameter protein foundation model outperform a 650M general-purpose model on the tasks that matter? SAN FRANCISCO , CA, UNITED STATES, August 12, 2026 /⁨EINPresswire.com⁩/ -- Ainnocence Inc., an AI-driven drug discovery company, today …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on August 3, 2026 - 16:00 GMT

Ainnocence Shows Its Protein Foundation Model Improves Antibody-Antigen Affinity Ranking by 28% - From Sequence Alone

Ainnocence’s foundation model trained from scratch, requiring no structure, no multiple sequence alignment, no fine-tuning, training in hours rather than weeks SAN FRANCISCO , CA, UNITED STATES, August 3, 2026 /⁨EINPresswire.com⁩/ -- Ainnocence Inc., an …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on July 20, 2026 - 16:00 GMT

Ainnocence Reports 91.4% Success Across 58 Antibody Affinity Maturation Campaigns, Opens 28-Program Biologics Pipeline

Structure-free AI platform delivers picomolar leads while cutting wet-lab validation to 20-50 samples per round SAN FRANCISCO , CA, UNITED STATES, July 20, 2026 /⁨EINPresswire.com⁩/ -- Ainnocence Inc., an AI-driven pharmaceutical & material IP- …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on June 12, 2026 - 14:00 GMT

Ainnocence Brings Its Protein, Antibody and Peptide AI Models to Production as Secure, On-Demand APIs

Three proprietary models: AINN-P1, AINN-Basemodel, AINN-Peptide are available as secure on-demand APIs that integrate directly into existing discovery pipelines SAN FRANCISCO , CA, UNITED STATES, June 12, 2026 /⁨EINPresswire.com⁩/ -- Ainnocence, Inc., a …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on April 15, 2026 - 16:00 GMT

Ainnocence PeptideAI Platform screens 3.2M peptides with 90%+ accuracy in activity and therapeutic property predictions

Foundation model-powered dual-module system establishes a new performance benchmark for AI-driven peptide drug discovery SAN FRANCISCO , CA, UNITED STATES, April 15, 2026 /⁨EINPresswire.com⁩/ -- Ainnocence, Inc. a next-generation AI drug discovery company …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on March 30, 2026 - 15:45 GMT

Ainnocence's CarbonAI®, a Proprietary AI Engine for De Novo Small-Molecule and PROTAC Design and Optimization

Platform screens up to 10 billion compounds in hours, delivering wet-lab-ready candidates in weeks without requiring 3D protein structures SAN FRANCISCO , CA, UNITED STATES, March 30, 2026 /⁨EINPresswire.com⁩/ -- Ainnocence, a next-generation AI drug …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on March 25, 2026 - 21:08 GMT

SentinusAI® Goes Live: Ainnocence’s AI Platform Turns Sequence Data Into Discovery Decisions in Days

The AI platform for therapeutic antibody and biologics discovery is now open for subscription. SAN FRANCISCO , CA, UNITED STATES, March 25, 2026 /⁨EINPresswire.com⁩/ -- The Challenge Therapeutic antibody development still depends heavily on structural …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on March 6, 2026 - 19:50 GMT

Ainnocence Calls for Collaboration to Deploy AI-Driven Antibody Discovery Against World’s Deadliest Infectious Diseases

A Study shows mutation-resistant antibodies with 269×affinity, a proof point for CEPI’s 100 Days Mission and closing the therapeutic gap for 2.5B people at risk SAN FRANCISCO , CA, UNITED STATES, March 6, 2026 /⁨EINPresswire.com⁩/ -- Ainnocence Inc., a …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on January 14, 2026 - 14:00 GMT

How sequence-based AI achieve whole genome screening for billions of small molecule and antibody candidates in hours

Destructed Drug Discovery: Sequence-Based AI for Rapid Evaluation of Small Molecules and Antibodies” SAN FRANCISCO , CA, UNITED STATES, January 14, 2026 /⁨EINPresswire.com⁩/ -- Ainnocence today announced a major milestone in artificial-intelligence driven …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on January 9, 2026 - 00:00 GMT

NatmolAI™: Computational Expansion and Optimization of Natural-Product Chemical Space

SAN FRANCISCO , CA, UNITED STATES, January 8, 2026 /⁨EINPresswire.com⁩/ -- Ainnocence, a next-generation AI-driven biotechnology company, announces NatmolAI™, a sequence-first molecular design platform focused on the discovery and engineering of natural- …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on January 1, 2026 - 09:02 GMT

Beauty Engineered: Ainnocence Launches CosmeticAI™ to Accelerate AI-Driven Innovation in Skincare and Beauty Products

SAN FRANSICO, CA, UNITED STATES, January 1, 2026 /⁨EINPresswire.com⁩/ -- Ainnocence, a next-generation AI-driven biotechnology company, announces the CosmeticAI™, a sequence-first molecular design platform developed to engineer cosmetic and dermatological …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on December 19, 2025 - 07:52 GMT

AI Meets the Formula: Predictive Intelligence Redefines Chemical Design and Manufacturing

FormulaAI™, an AI-based platform that brings predictive modeling, process foresight and manufacturing intelligence into chemical development workflows SAN FRANCISCO , CA, UNITED STATES, December 18, 2025 /⁨EINPresswire.com⁩/ -- Ainnocence, a California- …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on December 12, 2025 - 07:33 GMT

From Code to Cure: Accelerating Oligonucleotide Design with AI

An Advanced AI Platform for Rapid, Precise Engineering of Oligonucleotide Therapeutics SAN FRANCISCO , CA, UNITED STATES, December 11, 2025 /⁨EINPresswire.com⁩/ -- Ainnocence, a California-based biotechnology company pioneering AI-native drug design is …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on December 6, 2025 - 19:11 GMT

Ainnocence Announces AI Platform for Material Performance Prediction and Process Optimization

An AI-based engineering platform built to transform the discovery, optimization of next-generation alloys, composites, functional materials and energy systems SAN FRANCISCO , CA, UNITED STATES, December 6, 2025 /⁨EINPresswire.com⁩/ -- Ainnocence, a next- …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on November 21, 2025 - 07:15 GMT

RNA Reimagined: Harnessing AI to Unlock mRNA and siRNA Therapies

Ainnocence introduces an AI-native RNA engineering platform built to accelerate the next wave of programmable genetic medicines. SAN FRANCISCO , CALIFORNIA, UNITED STATES, November 21, 2025 /⁨EINPresswire.com⁩/ -- Ainnocence, a next-generation AI biotech …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on November 8, 2025 - 18:03 GMT

Ainnocence Expands the Druggable Universe: Targeting Therapeutics without Structural Data

Ainnocence’s generative AI platform supports the design of novel proteins and antibodies to improve the pace and precision of drug discovery SAN FRANCISCO , CA, UNITED STATES, November 8, 2025 /⁨EINPresswire.com⁩/ -- Ainnocence, a next-generation AI …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on October 23, 2025 - 23:04 GMT

Antibody Design at Lightning Speed: AI-Driven Precision for Complex Targets

Ainnocence’s next-generation AI platform revolutionizes biologics discovery, achieving unprecedented scale, precision and speed in antibody and protein design. SAN FRANCISCO , CA, UNITED STATES, October 23, 2025 /⁨EINPresswire.com⁩/ -- Ainnocence, a next- …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on October 9, 2025 - 21:00 GMT

Beyond the Library: 10¹⁰ Virtual Compounds and Antibody Variants Screened Overnight by Ainnocence AI

AI-driven platform surpasses the limits of traditional drug discovery for both small molecules and antibodies, unlocking vast chemical and protein space SAN FRANCISCO , CA, UNITED STATES, October 9, 2025 /⁨EINPresswire.com⁩/ -- Ainnocence, a next- …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on September 25, 2025 - 22:00 GMT

Redefining Chemistry: How AI Shrinks Small-Molecule Discovery from Years to Weeks

SAN FRANCISCO, CA, UNITED STATES, September 25, 2025 /⁨EINPresswire.com⁩/ -- Ainnocence today unveiled a major advance in AI-driven small-molecule R&D, demonstrating how its platform compresses the upfront discovery cycle from years to mere weeks, …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on August 23, 2025 - 16:59 GMT

Ainnocence Achieves New Milestone with Protein Foundation Models

Proprietary sequence-first model rivals and in key areas surpasses the leading ProteinGym sequence-only baselines SAN FRANCISCO, CA, UNITED STATES, August 23, 2025 /⁨EINPresswire.com⁩/ -- Ainnocence, a pioneer in generative AI for biotechnology, today …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...